Invasive meningococcal disease epidemiology and characterization of Neisseria meningitidis serogroups, sequence types, and clones; implication for use of meningococcal vaccines

References

• Harrison LH, Pelton SI, Wilder-Smith A, Holst J, Safadi MA, Vazquez JA, Taha MK, LaForce FM, Von Gottberg A, Borrow R, et al. The Global Meningococcal Initiative: recommendations for reducing the global burden of meningococcal disease. Vaccine. 2011 Apr 18;29(18):3363–3371. doi:10.1016/j.vaccine.2011.02.058.
   PubMedGoogle Scholar
• Jafri RZ, Ali A, Messonnier NE, Tevi-Benissan C, Durrheim D, Eskola J, Fermon F, Klugman KP, Ramsay M, Sow S, et al. Global Epidemiology of invasive meningococcal disease. Popul Health Metr. 2013 Sep 10;11(1):17. doi:10.1186/1478-7954-11-17.
   PubMed Web of Science ®Google Scholar
• Borrow R, Da C, Ceyhan M, Christensen H, Ec D, Findlow J, Glennie L, Von GA, Kechrid A, Vázquez MJ, et al. Global Meningococcal Initiative (GMI). Meningococcal disease in the Middle East and Africa: findings and updates from the global meningococcal initiative. J Infect. 2017 Jul;75(1):1–11. doi:10.1016/j.jinf.2017.04.007.
   PubMed Web of Science ®Google Scholar
• Vázquez JA, Taha MK, Findlow J, Gupta S, Borrow R. Global Meningococcal Initiative: guidelines for diagnosis and confirmation of invasive meningococcal disease. Epidemiol Infect. 2016 Oct;144(14):3052–3057. doi:10.1017/S0950268816001308.
   PubMed Web of Science ®Google Scholar
• Sridhar S, Greenwood B, Head C, Plotkin SA, Sáfadi MA, Saha S, Taha MK, Tomori O, Gessner BD. Global incidence of serogroup B invasive meningococcal disease: a systematic review. Lancet Infect Dis. 2015 Nov;15(11):1334–1346. doi:10.1016/S1473-3099(15)00217-0.
   PubMed Web of Science ®Google Scholar
• Vuocolo S, Balmer P, Gruber WC, Jansen KU, Anderson AS, Perez JL, York LJ. Vaccination strategies for the prevention of meningococcal disease. Hum Vaccin Immunother. 2018 Mar;15:1–48.
   Web of Science ®Google Scholar
• Cohn AC, MacNeil JR, Clark TA, Ortega-Sanchez IR, Briere EZ, Meissner HC, Baker CJ, Messonnier NE. Centers for Disease Control and Prevention (CDC). Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2013 Mar 22;62(RR–2):1–28.
   PubMed Web of Science ®Google Scholar
• Ben-Shimol S, Dagan R, Schonmann Y, Givon-Lavi N, Keller N, Block C, Kassis I, Ephros M, Greenberg D. Dynamics of childhood invasive meningococcal disease in Israel during a 22-year period (1989-2010). Infection. 2013 Aug;41(4):791–798. doi:10.1007/s15010-013-0439-6.
   PubMed Web of Science ®Google Scholar
• Israel Center for Disease Control (2012) Notifiable infectious diseases in Israel, 60 years of surveillance 1951–2010. Publication No.342
   Google Scholar
• Stein-Zamir C, Abramson N, Zentner G, Shoob H, Valinsky L, Block C. Invasive meningococcal disease in children in Jerusalem. Epidemiol Infect. 2008 Jun;136(6):782–789. doi:10.1017/S0950268807009259.
   PubMed Web of Science ®Google Scholar
• Stein-Zamir C, Shoob H, Sokolov I, Kunbar A, Abramson N, Zimmerman D. The clinical features and long-term sequelae of invasive meningococcal disease in children. Pediatr Infect Dis J. 2014 Jul;33(7):777–779. doi:10.1097/INF.0000000000000282.
   PubMed Web of Science ®Google Scholar
• Valinsky L, Jaffe J, Keller N, Block C, Abramson N, Stein-Zamir C. A cluster of invasive meningococcal disease revealed by the characterization of a novel serogroup B meningococcal clone. Epidemiol Infect. 2016 Jan;144(1):183–188. doi:10.1017/S0950268815001296.
   PubMed Web of Science ®Google Scholar
• Ginsberg GM, Block C, Stein-Zamir C. Cost-utility analysis of a nationwide Vaccination programme against serogroup B meningococcal disease in Israel. Int J Public Health. 2016 Jul;61(6):683–692. doi:10.1007/s00038-016-0821-0.
   PubMed Web of Science ®Google Scholar
• Ministry of Health, Israel. Immunizations recommendations for travel abroad; Updated 2017 Mar. https://www.health.gov.il/Subjects/vaccines/Vaccinesabroad/Documents/travel2013.pdf
   Google Scholar
• Ministry of Health, Israel. Immunizations recommendations, special circumstances; Updated 2017 Aug. https://www.health.gov.il/UnitsOffice/HD/PH/epidemiology/td/docs/110_Tochen.pdf
   Google Scholar
• Donald RG, Hawkins JC, Hao L, Liberator P, Jones TR, Harris SL, Perez JL, Eiden JJ, Jansen KU, Anderson AS. Meningococcal serogroup B vaccines: estimating breadth of coverage. Hum Vaccin Immunother. 2017 Feb;13(2):255–265. doi:10.1080/21645515.2017.1264750.
   PubMed Web of Science ®Google Scholar
• Crum-Cianflone N, Sullivan E. Meningococcal Vaccinations. Infect Dis Ther. 2016 Jun 5;2:89–112. doi:10.1007/s40121-016-0107-0.
   PubMed Web of Science ®Google Scholar
• World Health Organization, Guidance for the development of evidence-based vaccination -related recommendations, 2017 Jan. http://www.who.int/immunization/sage/Guidelines_development_recommendations.pdf
   Google Scholar
• Whittaker R, Dias JG, Ramliden M, Ködmön C, Economopoulou A, Beer N, Pastore Celentano L. ECDC network members for invasive meningococcal disease. The epidemiology of invasive meningococcal disease in EU/EEA countries, 2004-2014. Vaccine. 2017 Apr 11;35(16):2034–2041. doi:10.1016/j.vaccine.2017.03.007.
   PubMed Web of Science ®Google Scholar
• Findlow J. Meningococcal group B vaccines. Hum Vaccin Immunother. 2013 Jun;9(6):1387–1388. doi:10.4161/hv.24689.
   PubMed Web of Science ®Google Scholar
• Sadarangani M, Pollard AJ. Can we control all-cause meningococcal disease in Europe? Clin Microbiol Infect. 2016 Dec 1;22(Suppl 5):S103–S112. doi:10.1016/j.cmi.2016.03.006.
   PubMed Web of Science ®Google Scholar
• Archer BN, Chiu CK, Jayasinghe SH, Richmond PC, McVernon J, Lahra MM, Andrews RM, McIntyre PB. Australian Technical Advisory Group on Immunization (ATAGI) meningococcal working party. epidemiology of invasive meningococcal B disease in Australia, 1999-2015: priority populations for vaccination. Med J Aust. 2017 Nov 6;207(9):382–387.
   PubMed Web of Science ®Google Scholar
• Deasy A, Read RC. Challenges for development of meningococcal vaccines in infants and children. Expert Rev Vaccines. 2011 Mar;10(3):335–343. doi:10.1586/erv.11.3.
   PubMed Web of Science ®Google Scholar
• Brehony C, Rodrigues CMC, Borrow R, Smith A, Cunney R, Moxon ER, Maiden MCJ. Distribution of Bexsero® Antigen Sequence Types (BASTs) in invasive meningococcal disease isolates: implications for immunisation. Vaccine. 2016 Sep 7;34(39):4690–4697. doi:10.1016/j.vaccine.2016.08.015.
   PubMed Web of Science ®Google Scholar
• Mowlaboccus S, Mullally CA, Richmond PC, Howden BP, Stevens K, Speers DJ, Keil AD, Bjørnstad ON, Perkins TT, Kahler CM. Differences in the population structure of Neisseria meningitidis in two Australian states: victoria and Western Australia. PLoS One. 2017 Oct 24;12(10). doi:10.1371/journal.pone.0186839.
   PubMed Web of Science ®Google Scholar
• Rodrigues CMC, Lucidarme J, Borrow R, Smith A, Cameron JC, Moxon ER, Maiden MCJ. Genomic surveillance of 4CMenB vaccine antigenic variants among disease-causing Neisseria meningitidis isolates, United Kingdom, 2010-2016. Emerg Infect Dis. 2018 Apr;24(4):673–682. doi:10.3201/eid2404.171480.
   PubMed Web of Science ®Google Scholar
• Flacco ME, Manzoli L, Rosso A, Marzuillo C, Bergamini M, Stefanati A, Cultrera R, Villari P, Ricciardi W, Ioannidis JPA, et al. Immunogenicity and safety of the multicomponent meningococcal B vaccine (4CMenB) in children and adolescents: a systematic review and meta-analysis. Lancet Infect Dis. 2018 Apr;18(4):461–472. doi:10.1016/S1473-3099(18)30048-3.
   PubMed Web of Science ®Google Scholar
• Ladhani SN, Borrow R, Andrews NJ. Growing evidence supports 4CMenB effectiveness. Lancet Infect Dis. 2018 Apr;18(4):370–371. doi:10.1016/S1473-3099(18)30051-3.
   PubMed Web of Science ®Google Scholar
• Parikh SR, Newbold L, Slater S, Stella M, Moschioni M, Lucidarme J, De Paola R, Giuliani M, Serino L, Gray SJ, et al. Meningococcal serogroup B strain coverage of the multicomponent 4CMenB vaccine with corresponding regional distribution and clinical characteristics in England, Wales, and Northern Ireland, 2007-08 and 2014-15: a qualitative and quantitative assessment. Lancet Infect Dis. 2017 Jul;17(7):754–762. doi:10.1016/S1473-3099(17)30170-6.
   PubMed Web of Science ®Google Scholar
• European Centre for Disease Prevention and Control. Expert opinion on the introduction of the meningococcal B (4CMenB) vaccine in the EU/EEA. Stockholm. ECDC; 2017 Dec.
   Google Scholar
• Ministry of health Israel. https://www.health.gov.il/UnitsOffice/HD/PH/epidemiology/Pages/epidemiology_report.aspx
   Google Scholar
• Population of Israel and Jerusalem district by Population Group (table 2.19). In: Statistical abstract of Israel Jerusalem, Israel 2017. http://www.cbs.gov.il/shnaton68/shnaton68.pdf
   Google Scholar
• Elias J, Harmsen D, Claus H, Hellenbrand W, Frosch M, Vogel U. Spatiotemporal analysis of invasive meningococcal disease, Germany. Emerg Infect Dis. 2006 Nov;12(11):1689–1695. doi:10.3201/eid1211.060682.
   PubMed Web of Science ®Google Scholar
• Abramson J. 2011. WINPEPI updated: computer programs for epidemiologists, and their teaching potential. Epidemiol Perspect Innovation. 8:1. doi:10.1186/1742-5573-8-1.
   PubMedGoogle Scholar